Hayley Lewthwaite
Overview
Explore the profile of Hayley Lewthwaite including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
294
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ekstrom M, Li P, Lewthwaite H, Bourbeau J, Tan W, Jensen D
Chest
. 2025 Mar;
PMID: 40081656
Background: Exertional breathlessness is a cardinal symptom of people with chronic airflow limitation (CAL) and can be evaluated using cardiopulmonary exercise testing (CPET). Research Question: Does abnormally high exertional breathlessness...
2.
Hiles S, Lewthwaite H, Clark V, Vertigan A, Smith A, McDonald V
Front Allergy
. 2025 Feb;
5:1464948.
PMID: 39973940
Introduction: Asthma and mental health problems co-occur at high rates. In context of a holistic approach to health, considering the extent to which social determinants relate to mental health in...
3.
Elmberg V, Zhou X, Lindow T, Hedman K, Malinovschi A, Lewthwaite H, et al.
PLoS One
. 2024 Dec;
19(12):e0302111.
PMID: 39693378
Background: Exertional breathlessness is a key symptom in cardiorespiratory disease and can be quantified using incremental exercise testing, but its prognostic significance is unknown. We evaluated the ability of abnormally...
4.
Hayes Jr D, Jennerich A, Coleman R, Abston E, Adamson G, Berger J, et al.
Am J Respir Crit Care Med
. 2024 Nov;
211(2):157-173.
PMID: 39531626
Pulmonary hypertension in children is progressive with wide variability in prognosis. This document provides an evidence-based clinical practice guideline for the management of children with progressive pulmonary hypertension despite optimal...
5.
Hamada Y, Gibson P, Harvey E, Stevens S, Lewthwaite H, Fricker M, et al.
J Allergy Clin Immunol Pract
. 2024 Nov;
13(2):333-342.e9.
PMID: 39515519
Background: Mepolizumab can induce an early response and clinical remission in people with severe eosinophilic asthma (SEA). Objective: To find whether early response to mepolizumab (100 mg) could predict future...
6.
Ekstrom M, Lewthwaite H, Jensen D
Curr Opin Support Palliat Care
. 2024 Nov;
18(4):191-198.
PMID: 39494536
Purpose Of Review: Breathlessness is a common, distressing and limiting symptom in people with advanced disease, but is challenging to assess as the symptom intensity depends on the level of...
7.
Ekstrom M, Lewthwaite H, Li P, Bourbeau J, Tan W, Jensen D
Chest
. 2024 Nov;
167(3):697-711.
PMID: 39490971
Background: COPD management is guided by the respiratory symptom burden, assessed using the modified Medical Research Council (mMRC) scale, the COPD Assessment Test (CAT), or both. Research Question: What are...
8.
Urroz Guerrero P, Gibson P, Lewthwaite H, Majellano E, Hiles S, McDonald V
BMC Public Health
. 2024 Oct;
24(1):3011.
PMID: 39478476
People with severe asthma often lead sedentary lifestyles, which adversely affects overall health and asthma-specific outcomes. To inform future sedentary behaviour- interventions, this study aimed to explore perceptions of sedentary...
9.
Hamada Y, Thomas D, Harvey E, Stevens S, Fricker M, Lewthwaite H, et al.
Eur Respir J
. 2024 Oct;
65(1).
PMID: 39401859
Background: Patients with severe eosinophilic asthma, characterised by a high disease burden, benefit from mepolizumab, which improves symptoms and reduces exacerbations, potentially leading to clinical remission in a subgroup. This...
10.
Williams M, Lewthwaite H, Brooks D, Johnston K
Healthcare (Basel)
. 2024 Sep;
12(18).
PMID: 39337154
Background: Explanations provided by healthcare professionals contribute to patient beliefs. Little is known about how healthcare professionals explain chronic breathlessness to people living with this adverse sensation. Methods: A purpose-designed...